Cell-Specific MRI Contrast Agents
Targeted diagnostic imaging (e.g., for cancer)
DevelopmentActive
Key Facts
Indication
Targeted diagnostic imaging (e.g., for cancer)
Phase
Development
Status
Active
Company
About Sanochemia Diagnostics
Sanochemia Diagnostics, founded in 1990 and headquartered in Neufeld an der Leitha, Austria, is a commercial-stage company and a significant player in the generic diagnostic imaging market. It leverages its integrated 'made in Austria' manufacturing capabilities to supply over 4 million units of established contrast agents annually to more than 50 countries. The company is strategically pivoting towards innovation, with a pipeline focused on novel, cell-specific MRI contrast agents and gadolinium-free technologies based on iron oxide nanoparticles, aiming to address unmet needs in patient populations with renal impairment and become a leader in niche MRI segments.
View full company profile